NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx

NCT01946867 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DEVICE: NBTXR3 activated by IMRT

Sponsor

Nanobiotix